Janssen Research & Development Archives

Xarelto (rivaroxaban) reduces risk of major amputation by 70% in peripheral...

24th November 2017

Bayer and its cooperation partner Janssen Research & Development have announced two publications of further data from the Phase III COMPASS study in The...

Write to us
Editor: Jocelyn Hudson [email protected]
Advertising: Rav Pankhania [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: Janssen Research & Development

Xarelto (rivaroxaban) reduces risk of major amputation by 70% in peripheral...